Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

MicroRNAs and cancer: short RNAs go a long way.

Ventura A, Jacks T.

Cell. 2009 Feb 20;136(4):586-91. doi: 10.1016/j.cell.2009.02.005.

2.

Epigenetic activation of tumor suppressor microRNAs in human cancer cells.

Saito Y, Jones PA.

Cell Cycle. 2006 Oct;5(19):2220-2. Epub 2006 Oct 1. Review.

PMID:
17012846
3.

microRNAs, RNA binding proteins and cancer.

Agami R.

Eur J Clin Invest. 2010 Apr;40(4):370-4. doi: 10.1111/j.1365-2362.2010.02279.x. Review.

PMID:
20486997
4.

Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.

Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G.

Biochem Biophys Res Commun. 2009 Feb 13;379(3):726-31. doi: 10.1016/j.bbrc.2008.12.098. Epub 2008 Dec 29.

PMID:
19116145
5.

Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases.

Tuna M, Machado AS, Calin GA.

Genes Chromosomes Cancer. 2016 Mar;55(3):193-214. doi: 10.1002/gcc.22332. Epub 2015 Dec 9. Review.

PMID:
26651018
6.

MicroRNAs in Cancer.

Garzon R, Calin GA, Croce CM.

Annu Rev Med. 2009;60:167-79. doi: 10.1146/annurev.med.59.053006.104707. Review.

PMID:
19630570
7.

Epigenetically regulated microRNAs and their prospect in cancer diagnosis.

Kita Y, Vincent K, Natsugoe S, Berindan-Neagoe I, Calin GA.

Expert Rev Mol Diagn. 2014 Jul;14(6):673-83. doi: 10.1586/14737159.2014.925399. Epub 2014 Jun 10. Review.

PMID:
24914586
8.

Tumor suppressor microRNAs: a novel non-coding alliance against cancer.

Blandino G, Fazi F, Donzelli S, Kedmi M, Sas-Chen A, Muti P, Strano S, Yarden Y.

FEBS Lett. 2014 Aug 19;588(16):2639-52. doi: 10.1016/j.febslet.2014.03.033. Epub 2014 Mar 26. Review.

9.

Modulation of cancer traits by tumor suppressor microRNAs.

Grammatikakis I, Gorospe M, Abdelmohsen K.

Int J Mol Sci. 2013 Jan 16;14(1):1822-42. doi: 10.3390/ijms14011822. Review.

10.

The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.

Vo DT, Qiao M, Smith AD, Burns SC, Brenner AJ, Penalva LO.

RNA Biol. 2011 Sep-Oct;8(5):817-28. doi: 10.4161/rna.8.5.16041. Epub 2011 Sep 1.

PMID:
21881409
11.

The role of miRNAs in cancer: from pathogenesis to therapeutic implications.

Seven M, Karatas OF, Duz MB, Ozen M.

Future Oncol. 2014 May;10(6):1027-48. doi: 10.2217/fon.13.259. Review.

PMID:
24941988
12.

Roles of small RNAs in tumor formation.

Di Leva G, Croce CM.

Trends Mol Med. 2010 Jun;16(6):257-67. doi: 10.1016/j.molmed.2010.04.001. Epub 2010 May 20. Review.

13.

Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy.

Chen Y, Fu LL, Wen X, Liu B, Huang J, Wang JH, Wei YQ.

Apoptosis. 2014 Aug;19(8):1177-89. doi: 10.1007/s10495-014-0999-7. Review.

PMID:
24850099
14.

The role of microRNAs in cancer.

Stahlhut Espinosa CE, Slack FJ.

Yale J Biol Med. 2006 Dec;79(3-4):131-40. Review.

15.

Oncomirs - microRNAs with a role in cancer.

Esquela-Kerscher A, Slack FJ.

Nat Rev Cancer. 2006 Apr;6(4):259-69. Review.

PMID:
16557279
16.

MicroRNAs as therapeutic targets and their potential applications in cancer therapy.

Cho WC.

Expert Opin Ther Targets. 2012 Aug;16(8):747-59. doi: 10.1517/14728222.2012.696102. Epub 2012 Jun 13. Review.

PMID:
22690697
17.

The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.

Babashah S, Soleimani M.

Eur J Cancer. 2011 May;47(8):1127-37. doi: 10.1016/j.ejca.2011.02.008. Epub 2011 Mar 12. Review.

PMID:
21402473
18.

MicroRNAs.

Fabbri M, Croce CM, Calin GA.

Cancer J. 2008 Jan-Feb;14(1):1-6. doi: 10.1097/PPO.0b013e318164145e. Review.

PMID:
18303474
19.

Epigenetic regulation of miRNAs in cancer.

Fabbri M, Calore F, Paone A, Galli R, Calin GA.

Adv Exp Med Biol. 2013;754:137-48. doi: 10.1007/978-1-4419-9967-2_6. Review.

PMID:
22956499
20.

The role of MicroRNA in chemical carcinogenesis.

Chen T.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2010 Apr;28(2):89-124. doi: 10.1080/10590501.2010.481477. Review.

PMID:
20552498

Supplemental Content

Support Center